EP1692101 - MERCAPTO-PHENYL-NAPHTHYL-METHANE DERIVATIVES AND PREPARATION THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 11.05.2012 Database last updated on 24.08.2024 | Most recent event Tooltip | 04.10.2013 | Lapse of the patent in a contracting state New state(s): HU | published on 06.11.2013 [2013/45] | Applicant(s) | For all designated states Council of Scientific and Industrial Research Rafi Marg New Delhi 110 001 / IN | [2011/27] |
Former [2006/34] | For all designated states COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH Rafi Marg New Delhi 110 001 / IN | Inventor(s) | 01 /
SANGITA Central Drug Research Inst., Chattar Manzil Palace Lucknow, 226 001 Uttar Pradesh / IN | 02 /
KUMAR, Atul Central Drug Research Inst., Chattar Manzil Palace Lucknow, 226 001 Uttar Pradesh / IN | 03 /
SINGH, Man Mohan Central Drug Research Inst., Chattar Manzil Palace Lucknow, 226 001 Uttar Pradesh / IN | 04 /
JAIN, Girish Kumar Central Drug Research Inst., Chattar Manzil Palace Lucknow, 226 001 Uttar Pradesh / IN | 05 /
MURTHY, Puvvada Sri Ramchandra Central Drug Research Inst., Chattar Manzil Palace Lucknow, 226 001 Uttar Pradesh / IN | 06 /
RAY, Suprabhat Central Drug Research Inst., Chattar Manzil Palace Lucknow, 226 001 Uttar Pradesh / IN | [2006/34] | Representative(s) | Schwarz, Albin, et al Schwarz & Partner Patentanwälte Wipplingerstrasse 30 1010 Wien / AT | [N/P] |
Former [2006/34] | Schwarz, Albin, et al Kopecky & Schwarz Patentanwälte Wipplingerstrasse 32/22 1010 Wien / AT | Application number, filing date | 03780487.9 | 23.12.2003 | [2006/34] | WO2003IB06247 | Priority number, date | US20030458401P | 31.03.2003 Original published format: US 458401 P | [2006/34] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2004087644 | Date: | 14.10.2004 | Language: | EN | [2004/42] | Type: | A1 Application with search report | No.: | EP1692101 | Date: | 23.08.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.10.2004 takes the place of the publication of the European patent application. | [2006/34] | Type: | B1 Patent specification | No.: | EP1692101 | Date: | 06.07.2011 | Language: | EN | [2011/27] | Search report(s) | International search report - published on: | EP | 14.10.2004 | Classification | IPC: | C07C317/22, C07C317/24, C07C323/19, C07C323/22, C07C323/25, C07D295/088, A61K31/10, A61K31/12, A61K31/145, A61K31/222, A61K31/40, A61K31/4453, A61P5/30 | [2006/34] | CPC: |
C07D295/088 (EP,US);
A61P19/08 (EP);
A61P25/28 (EP);
A61P35/00 (EP);
A61P5/30 (EP);
C07C317/22 (EP,US);
C07C317/24 (EP,US);
C07C323/19 (EP,US);
C07C323/22 (EP,US);
C07C323/25 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2006/34] | Title | German: | MERCAPTOPHENYLNAPHTHYLMETHAN-DERIVATE UND DEREN HERSTELLUNG | [2006/34] | English: | MERCAPTO-PHENYL-NAPHTHYL-METHANE DERIVATIVES AND PREPARATION THEREOF | [2006/34] | French: | DERIVES DE MERCAPTO-PHENYLE-NAPHTHYLE-METHANE ET LEUR PREPARATION | [2006/34] | Entry into regional phase | 31.10.2005 | National basic fee paid | 31.10.2005 | Designation fee(s) paid | 31.10.2005 | Examination fee paid | Examination procedure | 22.07.2005 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 31.10.2005 | Examination requested [2006/34] | 23.03.2007 | Despatch of a communication from the examining division (Time limit: M06) | 02.10.2007 | Reply to a communication from the examining division | 26.10.2007 | Despatch of a communication from the examining division (Time limit: M06) | 30.04.2008 | Reply to a communication from the examining division | 15.09.2008 | Date of oral proceedings | 10.10.2008 | Minutes of oral proceedings despatched | 20.10.2008 | Communication of intention to grant the patent | 17.02.2009 | Fee for grant paid | 17.02.2009 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 23.03.2007 | Opposition(s) | 11.04.2012 | No opposition filed within time limit [2012/24] | Fees paid | Renewal fee | 28.12.2005 | Renewal fee patent year 03 | 27.12.2006 | Renewal fee patent year 04 | 28.12.2007 | Renewal fee patent year 05 | 30.12.2008 | Renewal fee patent year 06 | 30.12.2009 | Renewal fee patent year 07 | 27.12.2010 | Renewal fee patent year 08 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 06.07.2011 | BE | 06.07.2011 | CY | 06.07.2011 | CZ | 06.07.2011 | DK | 06.07.2011 | EE | 06.07.2011 | FI | 06.07.2011 | HU | 06.07.2011 | IT | 06.07.2011 | NL | 06.07.2011 | RO | 06.07.2011 | SE | 06.07.2011 | SI | 06.07.2011 | SK | 06.07.2011 | TR | 06.07.2011 | BG | 06.10.2011 | GR | 07.10.2011 | ES | 17.10.2011 | PT | 07.11.2011 | IE | 23.12.2011 | LU | 23.12.2011 | CH | 31.12.2011 | LI | 31.12.2011 | MC | 31.12.2011 | [2013/45] |
Former [2013/44] | AT | 06.07.2011 | |
BE | 06.07.2011 | ||
CY | 06.07.2011 | ||
CZ | 06.07.2011 | ||
DK | 06.07.2011 | ||
EE | 06.07.2011 | ||
FI | 06.07.2011 | ||
IT | 06.07.2011 | ||
NL | 06.07.2011 | ||
RO | 06.07.2011 | ||
SE | 06.07.2011 | ||
SI | 06.07.2011 | ||
SK | 06.07.2011 | ||
TR | 06.07.2011 | ||
BG | 06.10.2011 | ||
GR | 07.10.2011 | ||
ES | 17.10.2011 | ||
PT | 07.11.2011 | ||
IE | 23.12.2011 | ||
LU | 23.12.2011 | ||
CH | 31.12.2011 | ||
LI | 31.12.2011 | ||
MC | 31.12.2011 | ||
Former [2013/29] | AT | 06.07.2011 | |
BE | 06.07.2011 | ||
CY | 06.07.2011 | ||
CZ | 06.07.2011 | ||
DK | 06.07.2011 | ||
EE | 06.07.2011 | ||
FI | 06.07.2011 | ||
IT | 06.07.2011 | ||
NL | 06.07.2011 | ||
RO | 06.07.2011 | ||
SE | 06.07.2011 | ||
SI | 06.07.2011 | ||
SK | 06.07.2011 | ||
BG | 06.10.2011 | ||
GR | 07.10.2011 | ||
ES | 17.10.2011 | ||
PT | 07.11.2011 | ||
IE | 23.12.2011 | ||
LU | 23.12.2011 | ||
CH | 31.12.2011 | ||
LI | 31.12.2011 | ||
MC | 31.12.2011 | ||
Former [2013/25] | AT | 06.07.2011 | |
BE | 06.07.2011 | ||
CY | 06.07.2011 | ||
CZ | 06.07.2011 | ||
DK | 06.07.2011 | ||
EE | 06.07.2011 | ||
FI | 06.07.2011 | ||
IT | 06.07.2011 | ||
NL | 06.07.2011 | ||
RO | 06.07.2011 | ||
SE | 06.07.2011 | ||
SI | 06.07.2011 | ||
SK | 06.07.2011 | ||
GR | 07.10.2011 | ||
ES | 17.10.2011 | ||
PT | 07.11.2011 | ||
IE | 23.12.2011 | ||
LU | 23.12.2011 | ||
CH | 31.12.2011 | ||
LI | 31.12.2011 | ||
MC | 31.12.2011 | ||
Former [2013/22] | AT | 06.07.2011 | |
BE | 06.07.2011 | ||
CY | 06.07.2011 | ||
CZ | 06.07.2011 | ||
DK | 06.07.2011 | ||
EE | 06.07.2011 | ||
FI | 06.07.2011 | ||
IT | 06.07.2011 | ||
NL | 06.07.2011 | ||
RO | 06.07.2011 | ||
SE | 06.07.2011 | ||
SI | 06.07.2011 | ||
SK | 06.07.2011 | ||
GR | 07.10.2011 | ||
ES | 17.10.2011 | ||
PT | 07.11.2011 | ||
IE | 23.12.2011 | ||
CH | 31.12.2011 | ||
LI | 31.12.2011 | ||
MC | 31.12.2011 | ||
Former [2012/49] | AT | 06.07.2011 | |
BE | 06.07.2011 | ||
CY | 06.07.2011 | ||
CZ | 06.07.2011 | ||
DK | 06.07.2011 | ||
EE | 06.07.2011 | ||
FI | 06.07.2011 | ||
IT | 06.07.2011 | ||
NL | 06.07.2011 | ||
RO | 06.07.2011 | ||
SE | 06.07.2011 | ||
SI | 06.07.2011 | ||
SK | 06.07.2011 | ||
GR | 07.10.2011 | ||
PT | 07.11.2011 | ||
IE | 23.12.2011 | ||
CH | 31.12.2011 | ||
LI | 31.12.2011 | ||
MC | 31.12.2011 | ||
Former [2012/47] | AT | 06.07.2011 | |
BE | 06.07.2011 | ||
CY | 06.07.2011 | ||
CZ | 06.07.2011 | ||
DK | 06.07.2011 | ||
EE | 06.07.2011 | ||
FI | 06.07.2011 | ||
IT | 06.07.2011 | ||
NL | 06.07.2011 | ||
RO | 06.07.2011 | ||
SE | 06.07.2011 | ||
SI | 06.07.2011 | ||
SK | 06.07.2011 | ||
GR | 07.10.2011 | ||
PT | 07.11.2011 | ||
IE | 23.12.2011 | ||
MC | 31.12.2011 | ||
Former [2012/33] | AT | 06.07.2011 | |
BE | 06.07.2011 | ||
CY | 06.07.2011 | ||
CZ | 06.07.2011 | ||
DK | 06.07.2011 | ||
EE | 06.07.2011 | ||
FI | 06.07.2011 | ||
IT | 06.07.2011 | ||
NL | 06.07.2011 | ||
RO | 06.07.2011 | ||
SE | 06.07.2011 | ||
SI | 06.07.2011 | ||
SK | 06.07.2011 | ||
GR | 07.10.2011 | ||
PT | 07.11.2011 | ||
MC | 31.12.2011 | ||
Former [2012/31] | AT | 06.07.2011 | |
BE | 06.07.2011 | ||
CY | 06.07.2011 | ||
CZ | 06.07.2011 | ||
DK | 06.07.2011 | ||
EE | 06.07.2011 | ||
FI | 06.07.2011 | ||
IT | 06.07.2011 | ||
NL | 06.07.2011 | ||
RO | 06.07.2011 | ||
SE | 06.07.2011 | ||
SI | 06.07.2011 | ||
SK | 06.07.2011 | ||
GR | 07.10.2011 | ||
PT | 07.11.2011 | ||
Former [2012/23] | AT | 06.07.2011 | |
BE | 06.07.2011 | ||
CY | 06.07.2011 | ||
CZ | 06.07.2011 | ||
EE | 06.07.2011 | ||
FI | 06.07.2011 | ||
IT | 06.07.2011 | ||
NL | 06.07.2011 | ||
RO | 06.07.2011 | ||
SE | 06.07.2011 | ||
SI | 06.07.2011 | ||
SK | 06.07.2011 | ||
GR | 07.10.2011 | ||
PT | 07.11.2011 | ||
Former [2012/21] | AT | 06.07.2011 | |
BE | 06.07.2011 | ||
CY | 06.07.2011 | ||
CZ | 06.07.2011 | ||
FI | 06.07.2011 | ||
NL | 06.07.2011 | ||
SE | 06.07.2011 | ||
SI | 06.07.2011 | ||
GR | 07.10.2011 | ||
PT | 07.11.2011 | ||
Former [2012/12] | AT | 06.07.2011 | |
BE | 06.07.2011 | ||
CY | 06.07.2011 | ||
FI | 06.07.2011 | ||
NL | 06.07.2011 | ||
SE | 06.07.2011 | ||
SI | 06.07.2011 | ||
GR | 07.10.2011 | ||
PT | 07.11.2011 | ||
Former [2012/11] | AT | 06.07.2011 | |
BE | 06.07.2011 | ||
FI | 06.07.2011 | ||
NL | 06.07.2011 | ||
SE | 06.07.2011 | ||
SI | 06.07.2011 | ||
GR | 07.10.2011 | ||
PT | 07.11.2011 | ||
Former [2012/10] | BE | 06.07.2011 | |
FI | 06.07.2011 | ||
NL | 06.07.2011 | ||
SE | 06.07.2011 | ||
SI | 06.07.2011 | ||
GR | 07.10.2011 | ||
PT | 07.11.2011 | ||
Former [2012/09] | BE | 06.07.2011 | |
FI | 06.07.2011 | ||
NL | 06.07.2011 | ||
SI | 06.07.2011 | ||
PT | 07.11.2011 | ||
Former [2012/08] | NL | 06.07.2011 | |
SI | 06.07.2011 | ||
Former [2011/52] | SI | 06.07.2011 | Cited in | International search | [X]EP0488602 (ICI PLC [GB], et al) [X] 1,3,5-21,55,58-79 * example 2, compound 6f *; | JPH05170754 [ ] (NIPPON SODA CO); | [X]WO9737984 (UNION PHARMA SCIENT APPL [FR], et al) [X] 1,3-21 * examples 165,166 *; | [A]US6410564 (BRYANT HENRY U [US], et al) [A] 1-105* whole document *; | [X]WO02100903 (CIBA SC HOLDING AG [CH], et al) [X] 1,3,5-21 * example 14 *; | [X] - YANG, GUOQIANG ET AL, "Triplet state and photolysis of S-phenyl 1-thionaphthoate", JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY, A: CHEMISTRY, (1996), vol. 99, no. 1, pages 45 - 50, XP001181402 [X] 1,2,5-21 * Scheme 2: 4-thiobenzoyl 1-naphthalene * DOI: http://dx.doi.org/10.1016/1010-6030(96)04354-7 | [X] - YOSHINAKA, SHINJI ET AL, "Preparation of monoglycidyloxy compound", CAPLUS, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 1994:42022, URL: STN, XP002280767 [X] 1,2,5-21 * abstract * | by applicant | - "Recent developments in the chemotherapy of osteoporosis", DWIVEDI I; RAY S, Progress in Drug Research, (1995), vol. 45, pages 289 - 338 | - MARSHALL DH; HORSMANN A; NORDIN BEC, "The prevention and management of post- menopausal osteoporosis", ACTA OBSTET GYNECOL SCAND, (1977), vol. 65, pages 49 - 56 | - HUTCHINSON TA; POLANSKY SM; FEINSTEIN AR, "Postmenopausal estrogen protect against fractures of hip and distal radius: A care-control study", LANCET, (1979), vol. 2, pages 705 - 709 | - LOBO RA, "Cardiovascular implication of estrogen replacement therapy", OBSTETRICS & GYNAECOLOGY, (1990), vol. 75, pages 185 - 245 | - MENDELSON ME; KARAS RH, "Estrogen and the blood vessel wall", CURRENT OPINION IN CARDIOLOGY 1994, (1994), pages 619 - 626 | - STAMPFER MJ; COLDITZ GA, "Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiological evidence", PREVENTIVE MEDICINE, (1991), vol. 20, doi:doi:10.1016/0091-7435(91)90006-P, pages 47 - 63, XP023040594 DOI: http://dx.doi.org/10.1016/0091-7435(91)90006-P | - GRUBER CJ ET AL., "Production and actions of estrogens", THE NEW ENGLAND JOURNAL OF MEDICINE, (2002), vol. 346, pages 340 - 352 | - BELLINO FL; WISE PM, "Nonhuman primate models of menopause workshop", BIOLOGY OF REPRODUCTION, (2003), vol. 68, pages 10 - 18 | - LOBO RA, "Cardiovascular implication of estrogen replacement therapy", OBSTETRICS AND GYNAECOLOGY, (1990), vol. 75, pages 18S - 24S | - MEDELSON ME; KARAS RD, "Estrogen and the blood vessel wall", CURRENT OPINION IN CARDIOLOGY, (1994), vol. 9, pages 619 - 626 | - KNNEL WH; HJORTLAND M; MCNAMARA PM, "Menopause and risk of cardiovascular disease: The Framingham Study", ANN INT MED, (1976), vol. 8, pages 5447 - 5552 | - STAMPFER MJ; COLDITZ G, "Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiological evidence", PREVENTIVE MEDICINE, (1991), vol. 20, doi:doi:10.1016/0091-7435(91)90006-P, pages 47 - 63, XP023040594 DOI: http://dx.doi.org/10.1016/0091-7435(91)90006-P | - DHANDAPANI KM; BRANN DW, "Protective effects of estrogen and Selective Estrogen Receptor Modulators in the brain", BIOLOGY OF REPRODUCTION, (2002), vol. 67, doi:doi:10.1095/biolreprod.102.003848, pages 1379 - 1385, XP008041031 DOI: http://dx.doi.org/10.1095/biolreprod.102.003848 | - BERGKVIST L ET AL., "The risk of breast cancer after estrogen and estrogen-progestin replacement", N ENG J MED, (1989), vol. 321, pages 293 - 297 | - COIDITZ GA ET AL., "The use of estrogens and progestins and the risk of breast cancer in postmenopausal women", N ENG J MED, (1995), vol. 332, page 1593 | - BAUM M ET AL., "Endometrial cancer during tamoxifen treatment", LANCET, (1994), vol. 343, page 1291 | - CLEMONS M; DANSON S; HOWELL A, "Tamoxifen ('Nolvadex'): Antitumour treatment. A review", CANCER TREATMENT REVIEWS, (2002), vol. 28, pages 165 - 180 | - HUGGINS, C; YANG NC, "Induction and extinction of mammary cancer", SCIENCE, (1962), vol. 137, pages 257 - 262 | - WILLIAMS GM ET AL., "The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat", CARCINOGENESIS, (1993), vol. 10, pages 315 - 317 | - MEIER CR; JICK H, "Tamoxifen and risk of idiopathic venous thromboembolism", BR J CLIN PHARMACOL, (1998), vol. 45, pages 608 - 612 | - SINGH MM, "Centchroman, a selective estrogen receptor modulator, as contraceptive and in the management of hormone related clinical disorders", MEDICINAL RESEARCH REVIEWS, (2001), vol. 21, pages 302 - 347 | - "Clinical evaluation of centchroman: A new oral contraceptive", NITYANAND S ET AL., Hormone Antagonists for Fertility Regulation, INDIAN SOCIETY FOR THE STUDY OF REPRODUCTION AND FERTILITY, BOMBAY, (1988), pages 241 - 410 | - "Results of multicentric trial of centchroman", PURI V ET AL., Pharmacology for Health in Asia, (1988), pages 441 - 447 | - "Contraceptive efficacy and safety of centchroman with biweekly-cum-weekly schedule", NITYANAND S ET AL., Current Concepts in Fertility Regulation and Reproduction, WILEY EASTERN LTD, (1994), pages 61 - 68 | - NITYANAND S ET AL., "Centchroman: Current Status as a contraceptive", INDIAN PROGRESS IN FAMILY WELFARE, (1995), vol. 10, pages 26 - 31 | - NITYANAND S; ANAND N, "Centchroman: A nonsteroidal antifertility agent", FOGSI FOCUS, (1996), pages 8 - 10 | - ROY SN ET AL., "Induction of ovulation in human with centchroman, a preliminary report", FERTILITY AND STERILITY, (1976), vol. 41, pages 1108 - 1110 | - GOODMAN; GILMAN, The Pharmacological Basis of Therapeutics, MACMILLAN PUBLISHING COMPANY, (1985), pages 1321 - 1041 |